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BACKGROUND: Little is known about the frequency of
significant hypoglycemic events in actual practice. Lim-
ited health literacy (HL) is common among patients with
type 2 diabetes, may impede diabetes self-management,
and thus HL could increase the risk of hypoglycemia.
OBJECTIVE: To determine the proportion of ambulatory,
pharmacologically-treated patients with type 2 diabetes
reporting ≥1 significant hypoglycemic events in the prior
12 months, and evaluate whether HL is associated with
hypoglycemia.
RESEARCH DESIGN: Cross-sectional analysis in an
observational cohort, the Diabetes Study of Northern
California (DISTANCE).
SUBJECTS: The subjects comprised 14,357 adults with
pharmacologically-treated, type 2 diabetes who are seen
at Kaiser Permanente Northern California (KPNC), a non-
profit, integrated health care delivery system.
MEASURES: Patient-reported frequency of significant
hypoglycemia (losing consciousness or requiring outside
assistance); patient-reported health literacy.
RESULTS: At least one significant hypoglycemic episode
in the prior 12 months was reported by 11% of patients,
with the highest risk for those on insulin (59%). Patients
commonly reported limited health literacy: 53% reported
problems learning about health, 40% needed help
reading health materials, and 32% were not confident
filling out medical forms by themselves. After adjust-
ment, problems learning (OR 1.4, CI 1.1-1.7), needing
help reading (OR 1.3, CI 1.1-1.6), and lack of confidence
with forms (OR 1.3, CI 1.1-1.6) were independently
associated with significant hypoglycemia.
CONCLUSIONS: Significant hypoglycemia was a fre-
quent complication in this cohort of type 2 diabetes
patients using anti-hyperglycemic therapies; those
reporting limited HL were especially vulnerable. Efforts
to reduce hypoglycemia and promote patient safety may
require self-management support that is appropriate for
those with limited HL, and consider more vigilant
surveillance, conservative glycemic targets or avoidance
of the most hypoglycemia-inducing medications.
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INTRODUCTION
Maintaining optimal glycemic control for type 2 diabetes
has become a significant goal for health systems, providers,
and patients. Landmark studies have shown that lowering
blood glucose over the long term reduces microvascular
complications,1,2. However, unexpected excess mortality
recently reported in the ACCORD Trial, a randomized trial
exploring the effects of lowering blood glucose to near-
normal levels, has renewed the controversy about glycemic
targets3-6 and raised important questions regarding treat-
ment safety. One unintended consequence of optimizing
glycemic control may be an increased risk for hypoglycemic
events3 (Fig. 1).
Hypoglycemia is one of the most common adverse drug
events that lead to emergency room visits and hospitaliza-
tion,7,8 and reduces quality of life9,10. Although trials to
assess the benefits of optimizing glycemic control among type
2 diabetes patients have documented a low incidence of
hypoglycemia,11,12 hypoglycemia may be more common in
practice13, and little is known about the incidence of
hypoglycemia occurrences that do not come to medical
attention.
The relationship between limited health literacy and
hypoglycemia is unclear. Limited health literacy (HL) has
been found to be common among patients with type 2
diabetes14,15 and has been shown to be a barrier to adequate
self-management of medication regimens, with less compre-
hension of medication instructions, dosing, timing, and
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warnings16-18, which could lead to increased risk for
hypoglycemia.
We measured the occurrence of patient-reported signifi-
cant hypoglycemia in a large, diverse population of medica-
tion-treated patients with type 2 diabetes with uniform
access to care in an integrated managed care setting. We
hypothesized that adults with diabetes would report signif-
icant hypoglycemia more often in this observational cohort
than previously reported in clinical trials. We hypothesized
that even after adjustment for a host of potential confoun-
ders, limited health literacy would be associated with hypo-
glycemia in an observational study of diabetes patients.
METHODS
Study Population
The Diabetes Study of Northern California (DISTANCE) en-
rolled an ethnically-stratified, random sample of patients from
the Kaiser Permanente Northern California (KPNC) Diabetes
Registry, a large, ethnically diverse and well-characterized
population with diabetes. KPNC is a fully integrated health
care delivery system that provides comprehensive medical care
to over 3 million members (30% of the entire Northern
California population). Except for the extremes of income, the
demographic characteristics of KPNC’s patient population are
similar to those of the overall population of Northern Califor-
nia19.
The overarching aim of the DISTANCE study (available at
http://distancesurvey.org) was to investigate ethnic and edu-
cational disparities in diabetes-related behaviors, processes of
care and health outcomes. The survey methods and cohort
profile have been described previously20. The extensive survey
was conducted among an ethnically-stratified, random sample
of 40,735 diabetes patients, aged 30–75 at baseline, of known
(Caucasian, African-American, Latino, Asian) and unknown
ethnicity. Demographic, clinical, health care utilization and
census data were obtained from electronic (non-survey) data-
bases for the entire cohort. Briefly, three modes of the
DISTANCE Survey were offered to all patients in the sample:
self-administered written questionnaire, web-based survey, or
computer-assisted telephone interview (CATI) with interviews
conducted in English, Spanish, Cantonese, Mandarin or
Tagalog.
Surveys were completed by 20,188 patients (62% response
rate, according to AAPOR response rate #3 definition21).
Respondents were primarily (78%) of minority (non-White)
race/ethnicity and varied widely in clinical and behavioral
profiles, as well as education, income, wealth, occupation,
nativity and neighborhood characteristics. For this analysis,
we restricted our sample to respondents with type 2
diabetes (classified using a published algorithm22), since
the incidence and mechanism of hypoglycemia may differ
from type 1 diabetes23. We included only respondents taking
any hyperglycemic medications, since strictly diet-controlled
patients are generally not at risk for hypoglycemia24. We
were able to obtain complete laboratory, prescription,
emergency department and hospital utilization data from
Kaiser’s electronic records. This study was approved by the
institutional review boards at Kaiser Foundation Research
Institute.
Measures.
Outcome. We asked participants, “In the past year, how many
times have you had a SEVERE low blood sugar reaction, such
as passing out or needing help to treat the reaction?” This item
was drawn from the widely-used, well-validated Diabetes Care
Profile25-27, and is similar to the hypoglycemia reporting items
used in landmark diabetes trials and observational studies to
identify treatment-related adverse events1,11-13,28. Responses
were dichotomized into one or more episodes versus no
episode. We considered “don’t know” responses as missing.
Exposure. To obtain self-reported HL, we employed a slightly
modified version of a 3-item instrument that asks patients to
report problems due to reading, understanding, and filling out
forms, not due to poor vision: (a)“How often do you have
problems learning about your medical condition because of
difficulty understanding written information?”; (b) “How
confident are you filling out medical forms by yourself?”; (c)
“How often do you have someone like a family member, friend,
hospital or clinic worker or caregiver, help you read Kaiser
health plan materials (such as written information about your
health or care you are offered)?” This instrument has been
validated against direct HL measures29,30 in patients with
diabetes and across a variety of research settings30-32. In
keeping with prior studies, we dichotomized Likert responses
into ever having difficulties versus never having difficulties30.
We considered “don’t know” responses as missing. Each
question was analyzed separately, as the item authors
recommend29,30.
Analysis. First, we determined the frequency of reporting one or
more episodes of significant hypoglycemia in the overall
sample of pharmacologically treated patients with type 2
diabetes, then calculated its frequency across HL levels.
Second, we performed an unadjusted logistic regression by
regressing significant hypoglycemia on each HL question
individually. Third, we performed three separate multivariate
logistic regression analyses to assess the possible association
of each HL item with hypoglycemia, adjusted for the
demographic and clinical characteristics listed below and in
Figure 1. Proportion of patients reporting 1 or more significant
hypoglycemic events in past 12 months.
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Table 1. Because we used a stratified random sample (with
over-sampling of racial/ ethnic minority patients), we needed
to account for design effects by applying expansion weights
(reciprocal of the non-proportional sampling fractions for each
race) to multivariate models.
The multivariable analysis included age, sex, race/ethnicity,
non-English language, and household income. Because
hypoglycemia may be more common as renal function
declines, we also adjusted for the glomerular filtration rate
(GFR) using the MDRD equation33. We further adjusted for
diabetes duration, hemoglobin A1c (HbA1c), and whether
patients perform self-monitoring of blood glucose (SMBG),
based on a validated measure constructed from prescription
refill rates of glucose test strips22. We used diagnostic codes to
adjust for cognitive impairment and dementia (ICD9 2900x,
29020, 2904x, 2941x, 2948x, 2949x, 3310x, 3311x, 33182x,
33183, 78093x), and past history of stroke (ICD9 431.x, 433.x,
434.x, 436.x). Finally, because some medication regimens are
known to carry higher risk of hypoglycemia than others, we
categorized participants’ medication use, using pharmacy
prescription data over the 12 months prior to the survey, as
follows: (a) insulin alone or in combination with oral agents; (b)
oral secretagogues (such as sulfonylureas) alone; (c) metformin
alone; (d) mixed oral agents, and adjusted for type of regimen
in all analyses. We also explored the possible contribution of
body-mass index, problematic alcohol use, medication
adherence (continuous medication gap34), and neuropathy
(ICD 9 250.6x) in additional multivariable models.
We wished to address 2 types of response bias: survey non-
response and item non-response. For survey non-response, we
used the standard Horvitz-Thompson35 approach. This multi-
part model, first uses available data to calculate the probability
of survey response. The inverse of that fitted non-response
probability is then used to weight the complete observations.
Even among survey respondents, not all answered all
questions in the 52-page survey, leading to some missing
values for outcome, exposure (HL), and co-variates. Item non-
response is a common problem in lengthy surveys. Analysis
restricted to complete cases can introduce bias if the data are
not missing completely at random, and also reduce
precision36. Therefore, we used multiple imputation, as
implemented in SAS Proc MI37. Missing items were imputed
ten times under the assumption that they were missing, not
completely at random, but at random, given the covariates in
the imputation models; then the ten completed datasets were
each analyzed using complete data methods, and the results
combined using established methods that provide standard
errors, confidence intervals and p-values that properly reflect
the imputation of the missing items. Imputed values for binary
and categorical variables were rounded and truncated to the
nearest category38. Final parameter estimates, confidence
intervals, and significance tests were calculated using
standard methods for combining results across the ten
imputed data sets38,39, as implemented in Proc MIANALYZE.
In addition, we performed a sensitivity analyses using only
complete cases, those for whom no data were missing. Finally,
we examined whether the sample included in the current
analysis (those with pharmacologically-treated type 2
diabetes), exhibited demographic or clinical differences
compared to the survey respondents overall.
Because there may be underreporting of limited HL due to
shame16, we performed a sensitivity analysis in which we
assumed that those with “don’t know” responses to the HL
items had limited HL. We also explored hypothesized
interactions between HL and potential effect modifiers
including age, diabetes medication treatment, and survey
mode by adding cross-product terms to the model specified
above. To further evaluate the possibility that inaccurate
reporting of hypoglycemia contributed to our findings, we
performed a sensitivity analysis involving only the subgroup
(94%) that provided a correct answer to a hypoglycemia
knowledge item from the DISTANCE survey that asked “If a
person with diabetes suddenly gets sweaty, nervous, and
shaky, what should he or she do?” Finally, as an exploratory
analysis to further validate the outcome assessment, we
compared the odds of participants’ making an emergency
department visit or requiring a hospitalization for
hypoglycemia (International Classification of Disease Codes
250.8, 251.0, 251.1, 251.2) over the 3-year period prior to
survey completion between those who did versus did not report
significant hypoglycemia in the survey.
RESULTS
Of the 20,188 surveyed, 2,393 were excluded because they
completed a short-form of the survey which lacked the HL
items. We further excluded 826 because they did not have type
2 diabetes, and 2612 who did not take medication for type 2
Table 1. Subject Characteristics (N=14,357)
Characteristics N or mean (% or SD)
Age (y) 58 (10)
Female sex 7,068 (49)
Race/ Ethnicity
African-American 2,417 (17)
Non-Hispanic White 3,202 (22)
Latino/a 2,632 (18)
Asian 3,265 (23)
Other/Mixed 2,841 (20)
Limited English Proficiency 1,386 (10)
HbA1c% 7.6 (1.6)
Medication Type
Insulin 3,142 (22)
Secretagogues only 2,284 (16)
Metformin only 2,727 (19)
Mixed Oral Meds 6,205 (43)
Diabetes duration, yrs 10 (8)
Perform self-monitoring of blood glucose 6,934 (48)
Problems learning 7,617 (53)
Help reading 5,726 (40)
Not confident with forms 4,539 (32)
Dementia 159 (1)
Cerebrovascular disease/ stroke 382 (3)
Renal function
GFR >=90 2,087 (15)
GFR 60–89 7,069 (49)
GFR 30–59 3,037 (21)
GFR 15–29 219 (2)
GFR<15 135 (1)
Income
>$65,000 4,673 (33)
$35,000–$65,000 3,728 (26)
$25,000–$34,999 1,472 (10)
$15,000–$24,999 1,080 (8)
<$15,000 1,305 (9)
964 Sarkar et al.: Hypoglycemia in Type 2 Diabetes JGIM
diabetes. Thus, our overall sample was the 14,357 responders
with pharmacologically treated type 2 diabetes whom we asked
about health literacy. Subjects were ethnically-diverse, had
long-standing diabetes (average time since diagnosis approxi-
mately 10 years) and relatively well-controlled glycemia (aver-
age HbA1c of 7.6) (Table 1). The most common medication
regimen was mixed oral agents (43%), followed by insulin alone
or in combination with oral agents (22%), metformin alone
(19%), and secretagogues alone (16%). According to refill rate
of glucose test strips, 48% regularly self-monitor their blood
glucose (SMBG). Among all respondents, 53% reported pro-
blems learning about health, 40% needed help reading health-
care materials, and 32% were not confident with medical
forms, due to reading difficulties. We did not observe clinically
meaningful differences between the 14,357 we analyzed and
the 20,188 survey respondents (see online appendix Table 1).
Overall, 1,579 (11%) of participants reported experiencing at
least one significant hypoglycemic episode in the past year.
Hypoglycemia occurrence varied by medication regimen, with
the highest risk for those on insulin (59%) followed by, mixed
oral medication types (23%), secretagogues alone (13%) and
metformin alone (5%). Of these participants who reported at
least 1 significant hypoglycemic episode, 8% (129/1579) had
evidence of a documented emergency department visit or
hospitalization for hypoglycemia in the prior year, compared
to 1.6% (202/12,777) of the participants who reported not
having significant hypoglycemia, yielding an odds ratio of 19.0
(95% CI 13.0–26.0).
A significantly higher proportion of patients reporting
limited HL experienced significant hypoglycemia (p for all
<0.0001; Figure). This pattern was consistent across all three
HL questions, with each accompanying analysis yielding very
similar effect sizes (Table 2). These relationships did not
change substantively with adjustment for patient factors (age,
sex, race/ethnicity, language, income, social support, diabetes
factors (glycemic control, diabetes duration, treatment regi-
men, SMBG practice), and renal function. In additional models
further adjusted for body-mass index, alcohol use, medication
adherence, and neuropathy, the relationship between HL and
hypoglycemia remained unchanged (see online appendix Ta-
ble 2.) While we found that those with limited HL were more
likely than those with adequate HL to respond by CATI than
either web or mailed written surveys (p for all <0.001), the
relationship between HL and hypoglycemia did not differ
significantly across survey modes (p-value for all HL-survey
\mode cross-product terms >0.2). In stratified analyses,
neither age nor medication type substantively or significantly
modified the HL-hypoglycemia relationships. Results did not
differ substantively in the complete-case only analysis. In a
sensitivity analysis that excluded all participants who did not
demonstrate knowledge of hypoglycemia symptoms and treat-
ment, results remained substantively unchanged. When we
classified participants who responded “don’t know” to the
health literacy questions as limited health literacy, the results
did not change. Finally, our results were substantively un-
changed in an analysis re-weighted for the inverse probability
of survey response (data not shown).
CONCLUSIONS
Among ambulatory type 2 diabetes patients receiving care in a
well-integrated, managed-care system, we found that hypogly-
cemia is a significant problem. To our knowledge, this is the
largest observational study in the U.S. to assess significant
hypoglycemia. As prior studies would suggest40, the frequency
of significant hypoglycemia reported in this population was
significantly higher than reported in landmark trials. Annual
assistance-requiring hypoglycemia rates range from 0.7 per
100 overall for ADVANCE1 and 5.1% in the standard arm for
ACCORD41. In UKPDS, the highest rate of assistance-requiring
hypoglycemia was among insulin users in the intensive arm,
and was only 1.8%/year1. The prevalence of self-reported
hypoglycemia relative to emergency department visits or
hospitalizations coded for hypoglycemia suggests that (a) the
vast majority of events are cared for outside of the medical
setting, (b) clinicians and health systems may not fully
appreciate the scope of this problem and that (c) most patients
are choosing to self-manage any immediate consequences of
hypoglycemia without medical assistance. Whether patients
are developing and implementing strategies to avoid future
hypoglycemia events on their own, or in consultation with their
treating clinicians, is not known.
Hypoglycemia, while an important adverse event in and of
itself, contributes to poorer diabetes outcomes in other
domains. Recent work has shown that acute care visits for
hypoglycemia predict future risk for dementia among type 2
diabetes patients42. Many have suggested that those who
experience hypoglycemia may have lower rates of hypoglycemic
medication adherence for fear of recurrence43,44.
Significant hypoglycemia was especially common among
patients reporting limited HL, and this association persisted
even after adjusting for known and suspected correlates of HL
and hypoglycemia. There are several possible mechanisms by
which limited HL could increase hypoglycemia risk. First,
limited HL could lead to patient errors in timing or dosage of
diabetes medications16,45. Second, limited HL could interfere
with proper adjustment of diabetes medication in response to
changing caloric intake or energy expenditure46. Third, those
with limited HL may not correctly interpret and respond to
their blood glucose values and trends obtained through
self-monitoring, potentially missing opportunities to adapt
self-management behaviors so as to prevent significant
hypoglycemia47. Importantly, mastery of such self-manage-
ment skills depends, in part, on adequate patient-clinician
communication. Limited HL has been shown to impede both
Table 2. Unadjusted and Adjusted Odds Ratios of Experiencing
Significant Hypoglycemia (Versus Not) by Self-reported HL
Unadjusted Adjusteda
Odds Ratio (95% CI) Odds Ratio (95% CI)
Problems learning 1.5 (1.3–1.8) 1.4 (1.1–1.7)
Need help reading 1.5 (1.3–1.8) 1.3 (1.1–1.6)
Not confident with
forms
1.5 (1.3–1.8) 1.3 (1.1–1.6)
aAdjusted for age, gender, race/ethnicity, English proficiency, medication
type, diabetes duration, HbA1c, glomerular filtration rate, income,
dementia and history of stroke.
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patients’ understanding of clinician information and instruc-
tions, and patients’ reporting of symptoms and disease state
to clinicians18.
Study strengths include a large, diverse population with
uniform access to care, and detailed assessments of HL and
hypoglycemic events within a real world setting. Neverthe-
less, this study has several limitations. First, the KPNC
system provides coordinated and uniform access to care,
including diabetes education and comprehensive care man-
agement. As such, our results may under-estimate hypogly-
cemic event rates in the under- and uninsured,48 or among
populations cared for in non-integrated health systems.
Second, because this is a cross-sectional analysis, we cannot
infer that limited HL was the cause of increased hypoglycemia
risk; although reverse causation is improbable, there may be
underlying factors affecting both. Third, we did not directly
measure HL, although the self-report HL items we used have
been validated against direct measurement instruments29,30.
Moreover, the degree to which these items exactly correlate
with HL as assessed by standard, ‘direct’ measurement may
be less relevant in practice, insofar as these questions have
predictive validity as they appear to identify subgroups at risk
for a clinically important adverse event. Fourth, we did not
measure numeracy in this study, so we could not address the
relative contribution of numeracy versus literacy. Numeracy
and literacy have been shown to be highly correlated. Fifth,
we could not capture attendance at diabetes education.
Sixth, not all participants answered every question in this
lengthy survey (184 questions, 52 pages). Nevertheless, this
remains the largest observational study of hypoglycemia, and
the subjects included in the analysis did not differ from the
overall sample in terms of age, race/ ethnicity, educational
attainment, which are the best predictors of health literacy,
or HbA1c, renal function, or medication type, the clearest
correlates of hypoglycemia. In addition, we used multiple
imputation to minimize the bias associated with missing
items36,38,39,49. Moreover, results using multiply imputed
data did not differ from the complete data-only approach.
Seventh, we could not explore individual medications within
each class. Finally, consistent with prior studies,1,10-13,50 we
obtained measures of hypoglycemia via patient self-report,
albeit an imperfect measure. Since self-report of mild hypo-
glycemia may be less accurate, we queried only clinically
significant episodes of losing consciousness or requiring
treatment assistance. The fact that we observed a stepwise
increase in hypoglycemia consistent with the established
pharmacologic risks of hypoglycemia from different medica-
tion regimens (i.e., highest in insulin-treated patients)
suggests the validity of patients’ reports. We also found that
self-report of hypoglycemia was strongly associated with
likelihood of making an emergency room visit or requiring
hospitalization for hypoglycemia during the year prior to the
survey, providing additional validation of this self-reported
measure. Furthermore, while it is possible that those with
limited HL were more likely to misattribute non-hypoglycemic
events to hypoglycemia, the results of our sensitivity analysis
that involved only those participants who demonstrated
accurate knowledge of hypoglycemia symptoms and treat-
ment suggest that outcome misclassification does not explain
our findings. It is theoretically possible that those with
limited HL reported more significant hypoglycemia because
they may require help for hypoglycemic episodes while those
with adequate HL can manage themselves. Such a height-
ened need for assistance would, in and of itself, place them at
greater risk.
Our findings have several clinical and health policy
implications. First, while it is unclear whether treating
clinicians’ actions (such as intensifying medications or
inadequate communication of safety precautions) contrib-
uted to these events or whether treating clinicians were aware
of patients’ hypoglycemic episodes, our results suggest that
hypoglycemic symptoms should be routinely assessed in
patients with type 2 diabetes receiving hyperglycemia-lower-
ing agents. Second, because insulin use confers a particu-
larly high risk for hypoglycemia, we recommend formal
hypoglycemia prevention counseling that is appropriate for
those with limited health literacy, as well as more vigilant
self-management support that includes training family mem-
bers and caregivers, at the time of insulin initiation. More
research is needed to (a) identify whether errors in patient
self-management are contributing to hypoglycemia, and (b)
determine what actions by patients, families, caregivers and
clinicians can reduce hypoglycemia. Third, hypoglycemia risk
profile should be an important criteria when choosing
medication regimen, favoring medications which are least
likely to cause hypoglycemia.
Hypoglycemia has been described as a sentinel adverse
event7 in type 2 diabetes that should trigger systems-based
approach to reduce recurrences. System-level surveillance
for hypoglycemia, perhaps through use of patient-directed
health information technology, may promote patient safety.
Between-visit surveillance mechanisms, utilizing technolo-
gies such as interactive voice response technology,30,5,52
personal health internet portals,53-55 or continuous blood
glucose monitors56,57 may be more sensitive in capturing
hypoglycemia than are current practices in diabetes manage-
ment. For example, patients receiving periodic automated
telephone self-management support for diabetes could input
a low blood glucose value into their telephone touchpad,
which would lead to a live telephone call with a care manager
as well as notification to the primary care provider. Such
technologies have the potential to make use of visual and
voice modalities so as to be appropriate for those with limited
HL, but this requires further investigation. Finally, from a
health policy perspective, our results suggest higher rates of
hypoglycemia than previously documented, raising the ques-
tion of whether widely-recommended clinical targets and
performance measures derived from efficacy studies, when
applied to real world contexts, may jeopardize the safety of
many patients with type 2 diabetes3,4.
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